Innovative Medicine

Innovative Medicine

August 29, 2012

FDA Approves NUCYNTA® ER (tapentadol) Extended-Release Oral Tablets for the Management of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy

Clinical Trial Data Demonstrate Efficacy and Safety for First Opioid Indicated for Patients with Painful Diabetic Peripheral Neuropathy

Innovative Medicine

August 23, 2012

Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis

Innovative Medicine

August 10, 2012

Crucell and Scripps Research discover and describe broad-spectrum antibodies against influenza B, a crucial link in development of universal flu therapies and vaccine

Landmark finding published in Science

Innovative Medicine

August 9, 2012

Updated Coding and Payment on the Horizon for Circulating Tumor Cell Testing

CMS Action May Provide Increased Access for Patients

Innovative Medicine

July 25, 2012

Janssen Healthcare Innovation Launches Care4Today™ Mobile Adherence Medication Reminder Platform

Free, secure mobile app and website designed to improve adherence to treatment regimens through self-directed reminders to take medications, refill prescriptions and visit healthcare providers

Innovative Medicine

July 23, 2012

Award-Winning Documentary, The Other City, Returns to Washington, D.C. for AIDS 2012

Janssen Therapeutics sponsors free film screenings and panel discussions with director Susan Koch, film participants and members of the HIV/AIDS community

Innovative Medicine

July 16, 2012

Janssen Submits Applications Requesting Approval Of SIMPONI® In U.S. And Europe For Treatment Of Moderately To Severely Active Ulcerative Colitis

Research

July 10, 2012

Janssen Research & Development, LLC, Sponsors First of its Kind Research Initiative to Advance Multiple Sclerosis Science

$5.4 Million in Funding Part of Healthy Minds Initiative

Innovative Medicine

July 10, 2012

Janssen Licenses Diabetes Research Programs From Evotec and Harvard University